121 results
Page 3 of 7
8-K
EX-99.1
zd9wabhz 9l35ggg
27 Apr 22
Agile Therapeutics Announces 1-FOR-40 Reverse Stock Split
7:21am
424B5
s0bta4zmz65m
27 Apr 22
Prospectus supplement for primary offering
6:30am
8-K
EX-99.1
c29b47 sh5wwunqyrp
14 Apr 22
Regulation FD Disclosure
4:15pm
424B5
jxg0hugwl ycj0qown
14 Mar 22
Prospectus supplement for primary offering
5:26pm
424B5
v4ranrov24tcg6
10 Jan 22
Prospectus supplement for primary offering
8:00am
8-K
EX-99.1
onkbtx 6fzue
2 Nov 21
Agile Therapeutics Reports Third Quarter 2021 Financial Results
4:11pm
8-K
EX-99.1
fqm7c
8 Oct 21
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
5:23pm
424B5
a7inpq0grnn8 o1dy
8 Oct 21
Prospectus supplement for primary offering
5:21pm
424B5
jet1i
7 Oct 21
Prospectus supplement for primary offering
5:24pm
8-K
EX-99.1
zzo1wi wcxt
4 Oct 21
Agile Therapeutics Announces Addition of Twirla® to a Preferred Drug Position on Medi-Cal Formulary
4:30pm
8-K
EX-99.1
vlo71
10 Sep 21
Regulation FD Disclosure
4:31pm
8-K
fwmvqi
10 Sep 21
Regulation FD Disclosure
4:31pm